Figure 5

![Figure 5: Comparative efficacy overview of melatonergic receptor agonists used in clinical practice for insomnia, including melatonin, tasimelteon, ramelteon, agomelatine, and selected herbal preparations.](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12472680/bin/molecules-30-03814-g005.jpg)

> Source: Kacper Żełabowski et al. "The Efficacy of Melatonergic Receptor Agonists Used in Clinical Practice in Inso." *Molecules (Basel, Switzerland)*, 2025. PMID: [41011705](https://pubmed.ncbi.nlm.nih.gov/41011705/)

<figure>
  <img src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12472680/bin/molecules-30-03814-g005.jpg" alt="Comparative efficacy overview of melatonergic receptor agonists used in clinical practice for insomnia, including melatonin, tasimelteon, ramelteon, agomelatine, and selected herbal preparations." />
  <figcaption>Figure 5. Comparative efficacy overview of melatonergic receptor agonists used in clinical practice for insomnia, including melatonin, tasimelteon, ramelteon, agomelatine, and selected herbal preparations.<br>  Source: Kacper Żełabowski et al. "The Efficacy of Melatonergic Receptor Agonists Used in Clinical Practice in Inso." <em>Molecules (Basel, Switzerland)</em>, 2025. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/41011705/">41011705</a></figcaption>
</figure>